Conclusion Not Excluding Drug Discount Agreement. According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Golimumab (Atc Code According To Who: L04Ab06)

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 119709941

  Document Type - Tender Notices

Description - Description: The subject of this publication is the conclusion of non-exclusive discount agreements in accordance with Section 130a Paragraph 8 SGB V for medicinal products with the active ingredient golimumab (ATC code according to WHO: L04AB06). Th e contract is concluded within the framework of a so-called open house model, i.e. h. The conclusion of a contract is open to all interested pharmaceutical companies within the participation period, provided they meet and accept the participation requirements. This means that individual contract negotiations are not carried out and (delivery) exclusivity is not given. It should be noted that the purchase quantity is unknown as it depends on deman

Gt Ref Id - 119709941

Deadline - Dec 31, 2026